GxP Readiness Kit NEO
Webinar Overview
Join us to find out about our new tools for Data Integrity (DI), compliance and good laboratory and manufacturing practices.
We will discuss our innovative DI framework which aligns to the very best industrial practices and integrates with a whole range of user defined workflows. Web and cloud based, it enables management of multiple instruments and multiple spectroscopies in a validated environment.
DI is fundamental to the consistent supply of quality medicines. The underlying principles, as exemplified by the term ALCOA, are well known and align very closely with the fundamental principles of scientific integrity. DI is a hot topic for the regulatory authorities who actively look for DI issues when conducting inspections and reviews.
There will be a Q&A open to the attendees to ask questions and the opportunity to book time with our specialist for demonstrations and further discussions.
Tuesday, October 13 2020
11 AM EST | 5 PM CET
Speakers
Dr. Ian Clegg
Regional Market Manager Bruker
Ian joined Bruker BioSpin in 2017 and his role is to work with customers to identify opportunities for the application of magnetic resonance to the pharma / biopharma industries. He then partners with internal and internal stakeholders to deliver solutions designed to improve the value chain. He also holds an additional role developing and implementing the Bruker BioSpin strategy to further support customers working in regulated environments. Prior to Bruker, he held various roles with Novartis and Pfizer, supporting late stage pharmaceutical development and manufacturing. Ian is a graduate of the University of Manchester (UK), with a B.Sc. in Chemistry and a Ph.D. in Measurement Science.
Anna Codina, Ph.D.
Senior Director Strategy and Business Development, SciY
Anna has a degree in Chemistry and a Ph.D. in Protein NMR from the University of Barcelona, Spain. She undertook her post-doc in protein NMR at the MRC Laboratory of Molecular Biology in Cambridge, UK, and following that worked in the Analytical R&D department of Pfizer for seven years, becoming proficient in low level impurity structure elucidation, reaction monitoring, qNMR and the preparation of regulatory documentation. She received a Pfizer Worldwide Achievement Award for the implementation of reaction monitoring by NMR in an open access environment.
She joined Bruker in 2011 and had different roles since including Material Characterisation Laboratory Manager, Product Portfolio Manager and for several years was in charge of driving the Biopharmaceutical business at Bruker BioSpin. Anna recently moved to SciY as Senior Director of Strategy and Business Development.
Dr. Santi Dominguez
Co-Founder and CEO at Mestrelab Research
Santi cofounded Mestrelab in 2004, and has been its CEO since. He has wide ranging responsibilities in customer interaction, product specification and design and team and project management. He has presented and participated in multiple NMR and Mass Spectrometry conferences, such as ENC, SMASH, EUROMAR, ASMS and ACS National Meetings.
Dr. Fabrice Moriaud
Product Manager for GxP solutions, Bruker BioSpin
Fabrice Moriaud, Ph.D. is Product Manager for GxP solutions. In his role as Solutions Development Manager at Bruker BioSpin, he brings extensive experience in leading the development of solutions for the Pharma industry. Trained as a chemist, Fabrice has a strong academic background in EPR and NMR.